FT Options’s bluebird bio BLUE Stock Holding History

FT Options’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-97	Closed	-$70.3K	–	380
2016 Q2	$55K	Buy	+97	New	+$54.9K	0.05%	197
2016 Q1	–	Sell	-774	Closed	-$475K	–	296
2015 Q4	$644K	Buy	+774	New	+$773K	0.48%	54

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

FT Options's BLUE Position: Q3 2016 in Review

FT Options sold out of bluebird bio (BLUE) in Q3 2016, closing a stake of 97 shares — an estimated $70.3K sold.

FT Options first reported a position in BLUE in Q4 2015 and held it in 2 quarters. The position peaked at $644K in Q4 2015. 200 funds tracked by Wall St. Rank hold BLUE as of Q3 2016.

FT Options reported no remaining bluebird bio position as of Q3 2016 after selling out during the quarter.
FT Options sold 97 bluebird bio shares in Q3 2016, an estimated $70.3K.
FT Options first reported a position in bluebird bio in Q4 2015 and held it in 2 quarters.
FT Options's bluebird bio position peaked at $644K in Q4 2015.
200 funds tracked by Wall St. Rank held bluebird bio as of Q3 2016.

Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.